Lecozotan

Lecozotan (developmental code name SRA-333) is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. , the first Phase III clinical trial has been completed.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Lecozotan (developmental code name SRA-333) is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. , the first Phase III clinical trial has been completed.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359092371 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001359092371 · captured 2026-06-12 · ledger · version history

Cite this page as: encyclopegia.org, “Lecozotan”, snapshot enwiki-001359092371. https://encyclopegia.org/a/lecozotan

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.